Viewing Study NCT01010061


Ignite Creation Date: 2025-12-24 @ 12:31 PM
Ignite Modification Date: 2025-12-26 @ 8:43 AM
Study NCT ID: NCT01010061
Status: COMPLETED
Last Update Posted: 2018-09-14
First Post: 2009-11-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a)
Sponsor: Hoffmann-La Roche
Organization: